Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04510142
Other study ID # 5870
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 19, 2019
Est. completion date June 19, 2023

Study information

Verified date May 2022
Source Liverpool University Hospitals NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Survey of health of patients completing SONIA 2 study: A cross-sectional analysis by questionnaire


Description:

The Liverpool site will post the once only, short questionnaire (in the correct language using translated documents as appropriate) to the address of those patients who completed SONIA 2. Hospital approved translation services will be used. A return-addressed stamped envelope for ease of return will also be provided. Those who received nitisinone will be sent the nitisinone-administration questionnaire and those who did not receive nitisinone will be sent a no-nitisinone questionnaire


Recruitment information / eligibility

Status Recruiting
Enrollment 3
Est. completion date June 19, 2023
Est. primary completion date June 19, 2023
Accepts healthy volunteers No
Gender All
Age group 25 Years to 65 Years
Eligibility Inclusion Criteria: - Documented diagnosis of AKU. Age =16 years. Exclusion Criteria: - Not completed SONIA 2 study for the full 4-year duration.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United Kingdom The Royal Liverpool Hospital Liverpool

Sponsors (1)

Lead Sponsor Collaborator
Liverpool University Hospitals NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary to collect information on their health status since completing participation in SONIA 2 All of the SONIA 2 completed questionnaire data collection is completed by 2 Sept 2020 12 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04142671 - Individualised Gait Modification Strategies in Alkaptonuria Patients N/A
Completed NCT04196959 - Evaluation of TYR Sphere N/A
Completed NCT01828463 - Dose Response Study of Nitisinone in Alkaptonuria Phase 2
Recruiting NCT00005909 - Study of Alkaptonuria
Completed NCT01390077 - Nitisinone (NTBC) In Different Age Groups Of Patients With Alkaptonuria Phase 2/Phase 3
Completed NCT00107783 - Long-Term Study of Nitisinone to Treat Alkaptonuria Phase 2
Active, not recruiting NCT01916382 - Suitability of Nitisinone in Alkaptonuria 2 Phase 3
Not yet recruiting NCT06298292 - Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies